Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Neogen shows improving operational execution with a stable revenue base, cost savings initiatives, and positive industry tailwinds. The stock exhibits positive technical momentum and analyst upgrades. Legal headwinds remain but ongoing margin expansion and upcoming earnings confer cautious near-term upside potential.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong Liquidity ⢠Persistent Losses ⢠High Leverage NEOG has strong liquidity and positive cash flow, but losses, heavy debt, high intangibles, and elevated valuation warrant caution.
Price Behavior
Key Price Behavior Insights: ⢠Higher highs ⢠Breakout momentum ⢠Overbought risk Support Level: $12.55â$12.25 Resistance Level: $13.00 NEOG's last-month uptrend and breakout above $12.15 remain bullish, but an RSI near 81 makes chasing $13.00 risky unless $12.55â$12.25 support holds.
Sentiment & News
Key News Insights: ⢠Share-price surge ⢠Institutional buying ⢠Strategy catalysts Neogen's strong share momentum, institutional buying, and upcoming Investor Day/earnings catalysts support optimism, though debt and competition remain key risks.
AI Summary
NEOG's investment case has shifted to proving that Food Safety growth and operational initiatives can deliver durable free cash flow and deleveraging, but at ~18x EV/EBITDA after a 100% rally, investors should wait for October evidence of sustained margins and resolution of Animal Safety supply disruptions before adding exposure.
Description
Neogen Corporation develops, manufactures and sells products used to detect, mitigate and monitor biological, chemical and sanitary hazards across the food and animal sectors. Its Food Safety business supplies diagnostic test kits and sanitation assays to food and feed producers, processors, grain handlers, dairies, laboratories and related manufacturers to identify pathogens, toxins, residues, allergens and other contaminants, while its Animal Safety business provides veterinary medicines, vaccines, diagnostic tools, disinfectants and genomics services, including drug-residue and toxicology testing for animals. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jan 1 | Jan 8 | NEOG | Neogen Corporation | Neogen shows improving operational execution with a stable revenue base, cost savings initiatives, and positive industry tailwinds. The stock exhibits positive technical momentum and analyst upgrades. Legal headwinds remain but ongoing margin expansion and upcoming earnings confer cautious near-term upside potential. | Closed | +38.9% |